BRAF and melanoma: Furthermore, MAPK pathways were shown to interact with enhanced glutamine metabolism in melanoma cells: In BRAF-mutated melanoma cells that were MAPK inhibitor-resistant, a greater uptake of glutamine and an increased sensitivity to glutamine was demonstrated compared to MAPK inhibitor-sensitive cells [64].